Mark Hlatky, MD
Publication Details
-
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.
JAMA. 2007; (22): 2502-14
Left ventricular (LV) systolic dysfunction causes substantial morbidity and mortality, even with optimal pharmacotherapy. Atrial-synchronized biventricular pacemakers (cardiac resynchronization therapy [CRT]) received US Food and Drug Administration (FDA) approval for use in selected patients with LV systolic dysfunction in 2001.
Help